← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $290K of BioMarin Pharmaceutical Inc.

Sold$290,460
$96.82Price
3,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Tue, Jan 22. Filed Thu, Jan 24, 7:07 PM ET, after the close. Not investment advice.